Home  |  Contact Us  |  Site Map
| MENU |

Skin Cancer in Organ Transplant Recipients

Prevention and early detection of skin cancer is of the utmost importance.

Organ transplant recipients are at increased risk of developing skin cancer compared to the general population. The immunosuppressive medications that allow the transplanted organ to function and survive also increase the risk of skin cancer. Most skin cancer is easily cured if recognized and treated early. Most transplant recipients will have few skin cancers; however, a few will have hundreds of skin cancers. For patients with many skin cancers, the extensive and repeated treatments may result in significant tissue loss and scarring, sometimes effecting appearance and the ability to function normally. The occurrence of skin cancer can decrease the quality of life for organ recipients. Aggressive skin cancers can potentially lead to death. Skin cancer may be a preventable disease, so efforts should be made to prevent it. If skin cancer does occur, early identification and treatment is very important.


Your tax-deductible donation supports the education and research of physicians and scientists committed to improving the quality of life of organ transplant recipients. If you are unable to donate online or require other information to make a gift through a trust or other source, email info@itscc.org for additional assistance. ITSCC's federal tax ID is 43-1964114.

Support ITSCC video

ITSCC is a nonprofit 501(c)(3) organization, and has received support through unrestricted educational grants from pharmaceutical companies and donations of time and funds from physicians, researchers, transplant patients and their families.